News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
281,404 Results
Type
Article (15044)
Company Profile (300)
Press Release (266056)
Multimedia
Podcasts (72)
Webinars (11)
Section
Business (80152)
Career Advice (159)
Deals (13400)
Drug Delivery (38)
Drug Development (50738)
Employer Resources (31)
FDA (5847)
Job Trends (5205)
News (145567)
Policy (10109)
Tag
Academia (924)
Accelerated approval (18)
Adcomms (14)
Allergies (76)
Alliances (21819)
ALS (119)
Alzheimer's disease (1016)
Antibody-drug conjugate (ADC) (218)
Approvals (6023)
Artificial intelligence (234)
Autoimmune disease (93)
Automation (9)
Bankruptcy (106)
Best Places to Work (4596)
BIOSECURE Act (6)
Biosimilars (97)
Biotechnology (230)
Bladder cancer (96)
Brain cancer (42)
Breast cancer (322)
Cancer (2940)
Cardiovascular disease (224)
Career advice (145)
Career pathing (6)
CAR-T (210)
CDC (5)
Cell therapy (540)
Cervical cancer (14)
Clinical research (43445)
Collaboration (1020)
Company closure (2)
Compensation (545)
Complete response letters (35)
COVID-19 (1093)
CRISPR (81)
C-suite (475)
Cystic fibrosis (107)
Data (4067)
Denatured (13)
Depression (79)
Diabetes (239)
Diagnostics (1368)
Digital health (9)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (169)
Drug pricing (42)
Drug shortages (3)
Duchenne muscular dystrophy (202)
Earnings (31667)
Editorial (23)
Employer branding (4)
Employer resources (29)
Events (51491)
Executive appointments (610)
FDA (7441)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (6)
Frontotemporal dementia (19)
Funding (906)
Gene editing (169)
Generative AI (18)
Gene therapy (457)
GLP-1 (486)
Government (1141)
Grass and pollen (3)
Guidances (162)
Healthcare (6648)
HIV (15)
Huntington's disease (38)
IgA nephropathy (68)
Immunology and inflammation (176)
Immuno-oncology (27)
Indications (50)
Infectious disease (1191)
Inflammatory bowel disease (150)
Inflation Reduction Act (10)
Influenza (35)
Intellectual property (152)
Interviews (18)
IPO (7355)
IRA (12)
Job creations (873)
Job search strategy (129)
Kidney cancer (9)
Labor market (22)
Layoffs (241)
Leadership (9)
Legal (1423)
Liver cancer (39)
Longevity (9)
Lung cancer (406)
Lymphoma (240)
Machine learning (21)
Management (7)
Manufacturing (337)
MASH (127)
Medical device (2667)
Medtech (2674)
Mergers & acquisitions (6617)
Metabolic disorders (671)
Multiple sclerosis (92)
NASH (13)
Neurodegenerative disease (205)
Neuropsychiatric disorders (62)
Neuroscience (1853)
NextGen: Class of 2025 (2056)
Non-profit (867)
Now hiring (28)
Obesity (297)
Opinion (122)
Ovarian cancer (122)
Pain (91)
Pancreatic cancer (142)
Parkinson's disease (210)
Partnered (12)
Patents (279)
Patient recruitment (287)
Peanut (42)
People (26636)
Pharmaceutical (45)
Pharmacy benefit managers (6)
Phase I (15368)
Phase II (20187)
Phase III (12777)
Pipeline (2588)
Policy (86)
Postmarket research (854)
Preclinical (6525)
Press Release (30)
Prostate cancer (138)
Psychedelics (48)
Radiopharmaceuticals (230)
Rare diseases (581)
Real estate (1453)
Recruiting (12)
Regulatory (9708)
Reports (19)
Research institute (970)
Resumes & cover letters (18)
Rett syndrome (21)
RNA editing (16)
RSV (16)
Schizophrenia (116)
Series A (170)
Series B (121)
Service/supplier (1)
Sickle cell disease (75)
Special edition (17)
Spinal muscular atrophy (118)
Sponsored (15)
Startups (2006)
State (1)
Stomach cancer (5)
Supply chain (31)
Tariffs (17)
The Weekly (58)
Vaccines (318)
Venture capital (58)
Weight loss (161)
Women's health (23)
Worklife (2)
Date
Last 7 days (68)
Last 30 days (943)
Last 365 days (18073)
2026 (17)
2025 (18108)
2024 (20573)
2023 (22473)
2022 (26916)
2021 (27874)
2020 (23473)
2019 (16363)
2018 (11834)
2017 (13810)
2016 (11926)
2015 (14461)
2014 (10488)
2013 (7570)
2012 (7617)
2011 (7688)
2010 (7480)
Location
Africa (154)
Alabama (63)
Alaska (2)
Arizona (66)
Arkansas (5)
Asia (18178)
Australia (3090)
California (6686)
Canada (1769)
China (714)
Colorado (232)
Connecticut (237)
Delaware (219)
Europe (39178)
Florida (840)
Georgia (202)
Hawaii (2)
Idaho (17)
Illinois (367)
India (31)
Indiana (151)
Iowa (8)
Japan (204)
Kansas (79)
Kentucky (9)
Louisiana (8)
Maine (11)
Maryland (708)
Massachusetts (5275)
Michigan (103)
Minnesota (239)
Mississippi (3)
Missouri (31)
Montana (15)
Nebraska (5)
Nevada (29)
New Hampshire (18)
New Jersey (1567)
New Mexico (12)
New York (1671)
North Carolina (788)
North Dakota (6)
Northern California (3247)
Ohio (171)
Oklahoma (11)
Oregon (22)
Pennsylvania (1213)
Puerto Rico (8)
Rhode Island (25)
South America (211)
South Carolina (9)
Southern California (2634)
Tennessee (37)
Texas (861)
United States (22109)
Utah (92)
Vermont (1)
Virginia (130)
Washington D.C. (36)
Washington State (560)
West Virginia (1)
Wisconsin (34)
281,404 Results for "omega therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Novo Partner Omega Waves Bankruptcy Flag from Sinking Ship
Just over a year after striking an obesity deal with Novo Nordisk, an SEC filing shows Flagship Pioneering spinout Omega Therapeutics is days away from bankruptcy and will lay off up to 17 employees.
February 4, 2025
·
1 min read
·
Kate Goodwin
Business
Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors
Omega Therapeutics, Inc. today announced the election of Richard N. Kender to its Board of Directors following its annual meeting of stockholders.
June 24, 2024
·
6 min read
Genetown
Omega Therapeutics To Participate In Two Upcoming Investor Conferences - May 30, 2024
Omega Therapeutics, Inc. today announced that management will participate in fireside chats at two upcoming investor conferences.
May 30, 2024
·
1 min read
Business
Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer
Omega Therapeutics, Inc., a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines, announced the appointment of Kaan Certel, Ph.D., as Chief Business Officer.
May 29, 2024
·
6 min read
Business
Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
Omega Therapeutics, Inc. announced financial results for the first quarter ended March 31, 2024, and highlighted recent Company progress.
May 6, 2024
·
10 min read
Business
Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update
Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”) today announced financial results for the fourth quarter and full year ended December 31, 2023, and a strategic prioritization initiative to focus resources on near-term milestones to support long-term shareholder value.
March 28, 2024
·
14 min read
Press Releases
Intrommune Therapeutics Announces Publication of OMEGA Study in Peanut Allergic Adults in Annals of Allergy, Asthma & Immunology
February 19, 2025
·
4 min read
Business
Novo Nordisk enters into research collaborations with Omega Therapeutics and Cellarity on novel treatment approaches for cardiometabolic diseases
Novo Nordisk, Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”) and Cellarity Inc. today announced that Novo Nordisk has entered into separate research collaborations with each company.
January 4, 2024
·
12 min read
Genetown
Omega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024
Omega Therapeutics, Inc. announced that it will present two posters at the American Association for Cancer Research Annual Meeting 2024, taking place in San Diego, California, April 5 – 10, 2024.
March 6, 2024
·
5 min read
Genetown
Omega Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”) today announced that management will present at the 42nd Annual J.P. Morgan Healthcare Conference taking place in San Francisco on Thursday, January 11, 2024, at 9:45 a.m. PT (12:45 p.m. ET).
January 2, 2024
·
1 min read
1 of 28,141
Next
